Cargando…

Differential glycosylation of envelope gp120 affects reactivity with HIV-1 specific antibodies

Detalles Bibliográficos
Autores principales:	Czernekova, Lydie, Raska, Milan, Moldoveanu, Zina, Zachova, Katerina, Hall, Stacy, Badalova, Dita, Krcmarska, Alzbeta, Synkova, Hana, Hoelscher, Michael, Maboko, Leonard, Brown, Rhubell, Novak, Zdenek, Mestecky, Jiri, Novak, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220993/ http://dx.doi.org/10.1186/1471-2334-14-S2-P68

Ejemplares similares

Differential glycosylation of envelope gp120 is associated with differential recognition of HIV-1 by virus-specific antibodies and cell infection
por: Raska, Milan, et al.
Publicado: (2014)

Glycosylation Patterns of HIV-1 gp120 Depend on the Type of Expressing Cells and Affect Antibody Recognition
por: Raska, Milan, et al.
Publicado: (2010)

Role of Epstein-Barr Virus in Pathogenesis and Racial Distribution of IgA Nephropathy
por: Zachova, Katerina, et al.
Publicado: (2020)

Signal peptide of HIV envelope protein impacts glycosylation and antigenicity of gp120
por: Yolitz, Jason, et al.
Publicado: (2018)

The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy
por: Knoppova, Barbora, et al.
Publicado: (2016)

Cytokines Alter IgA1 O-Glycosylation by Dysregulating C1GalT1 and ST6GalNAc-II Enzymes
por: Suzuki, Hitoshi, et al.
Publicado: (2014)

Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120
por: Kong, Leopold, et al.
Publicado: (2013)

HIV-1 gp120 N-linked glycosylation differs between plasma and leukocyte compartments
por: Ho, Yung Shwen, et al.
Publicado: (2008)

Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection
por: Russell, Michael W., et al.
Publicado: (2020)

Effect of Glycosylation on an Immunodominant Region in the V1V2 Variable Domain of the HIV-1 Envelope gp120 Protein
por: Tian, Jianhui, et al.
Publicado: (2016)

Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by Antibodies
por: Wei, Qing, et al.
Publicado: (2020)

Effect of site-specific de-glycosylation on HIV gp120-specific CD4 T cell responses
por: Li, Hualin, et al.
Publicado: (2006)

Sequential Analysis of the N/O-Glycosylation of Heavily Glycosylated HIV-1 gp120 Using EThcD-sceHCD-MS/MS
por: Zhang, Yong, et al.
Publicado: (2021)

Enzymatic Sialylation of IgA1 O-Glycans: Implications for Studies of IgA Nephropathy
por: Takahashi, Kazuo, et al.
Publicado: (2014)

Evolution of the HIV-1 envelope glycoproteins with a disulfide bond between gp120 and gp41
por: Sanders, Rogier W, et al.
Publicado: (2004)

Structural Plasticity and Conformational Transitions of HIV Envelope Glycoprotein gp120
por: Korkut, Anil, et al.
Publicado: (2012)

Mass Spectrometry Approach and ELISA Reveal the Effect of Codon Optimization on N-Linked Glycosylation of HIV-1 gp120
por: Honarmand Ebrahimi, Kourosh, et al.
Publicado: (2014)

Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodies
por: Rusert, Peter, et al.
Publicado: (2011)

Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression
por: Maixnerova, Dita, et al.
Publicado: (2019)

Correction: Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression
por: Maixnerova, Dita, et al.
Publicado: (2019)

Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core
por: Borst, Andrew J, et al.
Publicado: (2018)

GalNAc-T14 may Contribute to Production of Galactose-Deficient Immunoglobulin A1, the Main Autoantigen in IgA Nephropathy
por: Jemelkova, Jana, et al.
Publicado: (2023)

Comparative Evaluation of HIV-1 Neutralization in External Secretions and Sera of HIV-1-Infected Women
por: Wei, Qing, et al.
Publicado: (2012)

Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
por: Suzuki, Hitoshi, et al.
Publicado: (2016)

Physiological Corticosterone Attenuates gp120-Mediated Microglial Activation and Is Associated with Reduced Anxiety-Like Behavior in gp120-Expressing Mice
por: Moss, Emaya M., et al.
Publicado: (2023)

Extensive glycoform heterogeneity in the gp120 envelope proteins used in the RV144 trial
por: Yu, B, et al.
Publicado: (2012)

HIV-1 gp120 envelope glycoprotein determinants for cytokine burst in human monocytes
por: Levast, Benoît, et al.
Publicado: (2017)

Differences in serum IgA responses to HIV-1 gp41 in elite controllers compared to viral suppressors on highly active antiretroviral therapy
por: Nabi, Rafiq, et al.
Publicado: (2017)

Structural Analysis of the Glycosylated Intact HIV-1 gp120–b12 Antibody Complex Using Hydroxyl Radical Protein Footprinting
por: Li, Xiaoyan, et al.
Publicado: (2017)

Autoantibodies Specific for Galactose-Deficient IgA1 in IgA Vasculitis With Nephritis
por: Suzuki, Hitoshi, et al.
Publicado: (2019)

Eliciting neutralizing antibodies with gp120 outer domain
por: Qin, Y, et al.
Publicado: (2012)

Internalization and Axonal Transport of the HIV Glycoprotein gp120
por: Berth, Sarah, et al.
Publicado: (2015)

Allosteric Modulation of the HIV-1 gp120-gp41 Association Site by Adjacent gp120 Variable Region 1 (V1) N-Glycans Linked to Neutralization Sensitivity
por: Drummer, Heidi E., et al.
Publicado: (2013)

Structural Dynamics of HIV-1 Envelope Gp120 Outer Domain with V3 Loop
por: Yokoyama, Masaru, et al.
Publicado: (2012)

Improving immunogenicity of HIV-1 envelope gp120 by glycan removal and immune complex formation
por: Kumar, R, et al.
Publicado: (2012)

HIV-1 Envelope Protein gp120 Promotes Proliferation and the Activation of Glycolysis in Glioma Cell
por: Valentín-Guillama, Gabriel, et al.
Publicado: (2018)

Durable cytotoxic immune responses against gp120 elicited by recombinant SV40 vectors encoding HIV-1 gp120 ± IL-15
por: McKee, Hayley J, et al.
Publicado: (2004)

Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41
por: Pu, Jing, et al.
Publicado: (2019)

Convergent HIV-1 Evolution upon Targeted Destabilization of the gp120-gp41 Interface
por: Torrents de la Peña, Alba, et al.
Publicado: (2021)

Conformational alterations in the CD4 binding cavity of HIV-1 gp120 influencing gp120-CD4 interactions and fusogenicity of HIV-1 envelopes derived from brain and other tissues
por: Gray, Lachlan, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ka2cja8grmm6qglcofvdt050ns